MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

    S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)

    Objective: To compare the relative incidence rates, at identical disease duration, of motor and nonmotor clinical milestones in the long-term disease course of Parkinson’s disease…
  • 2017 International Congress

    Where Are The Main Lesions That Cause Orthostatic Hypotension In Parkinson’s Disease ?

    R. Sengoku, M. Shibukawa, M. Yamazaki, K. Eguchi, M. Higashihara, D. Kaneda, Y. Nishina, K. Kanemaru, S. Murayama (Tokyo, Japan)

    Objective: To clarify the responsible lesion of orthostatic hypotension (OH) in Parkinson’s disease (PD) by measuring the catecholamine level and using a cardiac MIBG scintigraphy.…
  • 2017 International Congress

    Sleep quality in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel infusion

    O. De Fabregues, A. Ferré, O. Romero, J. Dot, M. Abu-Suboh, M. Quintana, J.R. Armengol, J. Alvarez-Sabin (Barcelona, Spain)

    Objective: To describe the effects of levodopa/carbidopa intestinal gel (LCIG) infusion on sleep quality in patients with advanced Parkinson's disease (PD).  Background: Worsening of sleep…
  • 2017 International Congress

    Impulsive-compulsive behaviors in patients with Parkinson´s disease in Kannur, India

    N. Svensson, S. Ovallath, R. Constantinescu (Göteborg, Sweden)

    Objective: The main aim of the project was to determine the frequency of impulsive compulsive behaviors (ICB) in patients with Parkinson´s disease (PD) in Kannur,…
  • 2017 International Congress

    Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

    M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)

    Objective: To explore the association between metabolic syndrome and Unified Parkinson Disease Rating Scale (UPDRS) scores.  Background: While studies suggest that metabolic syndrome increases the…
  • 2017 International Congress

    Predictors of cognitive impairment in multiple system atrophy

    M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

    Objective: To determine predictors of cognitive impairment in patients with multiple system atrophy (MSA). Background: Although dementia is not a diagnostic criteria for MSA, an…
  • 2017 International Congress

    Profound reduction of DAT-SPECT signal in multiple system atrophy (MSA)

    I. Toyoshima, T. Hatakeyama, E. Abe, C. Wada, M. Kobayashi, K. Obara (Yurihonjo, Japan)

    Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum in the patients with MSA-P and MSA-C, and to compare the progression…
  • 2017 International Congress

    Neuroactive steroids reverse the dopaminergic neurotransmission defectiveness in chronic hepatic (HE) encephalopathy: a possible involvement in HE related parkinsonism

    O. El Hiba, A. EL Khiat, H. Gamrani (EL Jadida, Morocco)

    Objective: In the present study, we describe the changes of the dopaminergic system occurring in the cirrhotic rats and concomitantly we investigated the effect of…
  • 2017 International Congress

    Development of a Clinician-reported Screening Tool to Identify Patients with Parkinson’s disease inadequately controlled on oral medications

    A. Antonini, P. Schmidt, P. Odin, L. Kleinman, A. Skalicky, K. Sail, Y. Jalundhwala, J. Zamudio, K. Onuk, T. Marshall, H. Fernandez (Venice, Italy)

    Objective: To identify key clinical indicators for Parkinson disease (PD) patients inadequately controlled with oral medications or eligible for device-aided treatments. Background: Identifying patients with…
  • 2017 International Congress

    Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

    E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

    Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley